QR Code

Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial

Objective:. To determine whether neoadjuvant chemotherapy (NAC) followed by total mesorectal excision (TME) and adjuvant chemotherapy (AC) is superior to TME followed by AC for very low-lying clinical (c) T3 rectal cancer. Background:. Preoperative radiation is widely used for preoperative treatment...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Yuichiro Tsukada, MD, PhD, Norio Saito, MD, PhD, Yuji Nishizawa, MD, PhD, Riki Ohno, MD, PhD, Fumihiko Fujita, MD, PhD, Keiji Koda, MD, PhD, Masayuki Ohue, MD, PhD, Eiji Shinto, MD, PhD, Akihiko Murata, MD, PhD, Yoshikazu Koide, MD, PhD, Koji Ikeda, MD, PhD, Hideaki Bando, MD, PhD, Motoko Suzuki, Toshihiro Misumi, PhD, Takayuki Yoshino, MD, PhD, Masaaki Ito, MD, PhD
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wolters Kluwer Health 2025-06-01
Rangatū:Annals of Surgery Open
Urunga tuihono:http://journals.lww.com/10.1097/AS9.0000000000000579
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite